SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001382963-18-000105
Filing Date
2018-05-25
Accepted
2018-05-25 17:23:15
Documents
1
Period of Report
2018-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1571
  Complete submission text file 0001382963-18-000105.txt   2961
Mailing Address C/O METABASIS THERAPEUTICS 9390 TOWNE CENTRE DRIVE, BLDG 300 SAN DIEGO CA 92121
Business Address
Beck John W (Reporting) CIK: 0001292404 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37428 | Film No.: 18862438

Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations